Search

everythinglearnresearchcommunity

for

Search:↓

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Nagashima-type palmoplantar keratosis in Asians is caused by a SERPINB7 gene mutation.

JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.

A new mutation in the CDH3 gene causes hair loss and vision problems in a young girl.

Two new mutations in the CDH3 gene cause hair loss and vision problems in a young girl.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

PKM2 is a promising target for heart repair and regeneration.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Interest in JAK inhibitors for alopecia areata increased significantly after FDA approval, highlighting the need for patient education.

Akt2 and SGK3 are both important for normal hair growth and development.

Baricitinib is the most effective treatment for alopecia areata.

Pachyonychia congenita is linked to a keratin gene on chromosome 17.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Altering the keratin 17 gene in mice hair follicles caused temporary hair issues, but changes were minimal and short-lived.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Lack of functional CYLD in mice leads to early aging and cancer.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Polyamines are crucial for skin tumor development, and inhibiting them can prevent tumors.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.